By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verastem, Inc. 

215 First Street
Suite 440
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-858-0338 Fax: n/a


Company News
Verastem, Inc. (VSTM) To Present New Data At The 12th International Mesothelioma Interest Group Conference 10/8/2014 10:08:57 AM
Verastem, Inc. (VSTM) Reports Second Quarter 2014 Financial And Corporate Results 8/8/2014 9:15:59 AM
Verastem, Inc. (VSTM) Presents Results And Updated Development Plans At Annual Research And Development Day 7/11/2014 9:35:24 AM
Verastem, Inc. (VSTM) To Ring The NASDAQ Stock Market Closing Bell 7/9/2014 10:21:13 AM
Verastem, Inc. (VSTM) To Ring The NASDAQ Stock Market Closing Bell And Host Annual Research And Development Day On July 10, 2014 7/8/2014 10:57:06 AM
Verastem, Inc. (VSTM) Release: The Potential of Targeting Cancer Stem Cells Through FAK Inhibition In Mesothelioma Reported In American Association for Cancer Research’s Cancer Discovery 6/24/2014 10:18:22 AM
Verastem, Inc. (VSTM) Announces Annual Research And Development Day And Webcast 6/18/2014 11:43:57 AM
Verastem, Inc. (VSTM) To Present At Upcoming Conferences 6/10/2014 6:49:12 AM
Verastem, Inc. (VSTM) Presents Updated Clinical Data From VS-6063 And Paclitaxel Combination Phase 1/1b Study In Patients With Ovarian Cancer At The 2014 American Society of Clinical Oncology Annual Meeting 6/2/2014 10:13:12 AM
Boston CEO Conference To Feature Ceos Of Aegerion Pharmaceuticals, Inc. (AEGR), Alkermes plc (ALKS), Alnylam Pharmaceuticals (ALNY), Flex Pharma, Genzyme Corporation (GENZ), Infinity Pharmaceuticals Inc. (INFI), OvaScience (OVAS), Sarepta Therapeutics (SRPT), Tesaro, Inc. (TSRO), Verastem, Inc. (VSTM) And Others June 4th And 5th 5/20/2014 7:03:42 AM